In the midst of a growing number of Benicar lawsuits filed over chronic diarrhea side effects and other symptoms linked to sprue-like enteropathy, an Iowa woman has brought a complaint against the makers of Azor, claiming the blood pressure drug, which contains the same active ingredient as Benicar, caused her to suffer major gastrointestinal problems. The Azor sprue-like enteropathy lawsuit was filed by Kalawatti Kay Scheffler and her husband, James, in the U.S. District Court for the Southern District of Iowa on November 6, and names as defendants Azor makers Forest Laboratories and Daiichi Sankyo. If you believe you have been adversely affected by side effects of Azor or another potentially dangerous pharmaceutical drug, our consumer advocates at the Consumer Justice Foundation can help put you in touch with a reputable drug injury attorney today.
Like Benicar, Azor is a hypertension medication used to reduce the risk of stroke and heart attack in patients with high blood pressure, and the drug combines Benicar’s active ingredient, olmesartan, with amlodipine, a calcium channel blocker that was sold under the brand name Norvasc. According to allegations raised in Scheffler’s lawsuit, side effects of Azor caused her develop sprue-like enteropathy, a condition characterized by symptoms like weight loss, chronic diarrhea and malnutrition. In her complaint, Scheffler states that she was prescribed Azor in January 2011, but did not realize that her gastrointestinal problems were being caused by the blood pressure drug, since Forest Laboratories and Daiichi Sankyo failed to provide consumers and the medical community with adequate warnings about the side effects of Azor.
Azor garnered approval from the FDA in 2007, and belongs to the Benicar family of hypertension drugs sold by Daiichi Sankyo and Forest Laboratories. While chronic diarrhea, weight loss and other sprue-like enteropathy symptoms associated with the use of Azor or Benicar typically subside when the medications are no longer in use, long-term complications of sprue-like enteropathy may include a permanent and debilitating condition known as villous atrophy, which can lead to digestion problems and food intolerances similar to Celiac disease. According to Scheffler, she now suffers from major medical problems that require regular monitoring, and will have to undergo testing, screening and treatment for life as a result of her alleged Azor-related side effects.
Although the widely-used Benicar blood pressure drug has been on the market in the United States for more than ten years, it wasn’t until June 2013 that consumers first became aware of the potential risk of sprue-like enteropathy from Benicar, thanks to a drug safety communication issued by the FDA warning about the link between Benicar and intestinal problems like chronic diarrhea. As a result of this risk, many former Benicar patients who believe they have been harmed by side effects of the hypertension drug are now pursuing product liability complaints against Forest Laboratories and Daiichi Sankyo. If you took Benicar or Azor in the past, and you have since been diagnosed with sprue-like enteropathy, contact a knowledgeable drug injury lawyer today for legal help.